Study evaluates intranasal insulin therapy for adults with mild cognitive impairment or Alzheimer’s

"Intranasal insulin stabilized or improved cognition, function and cerebral glucose metabolism for adults with mild cognitive impairment or Alzheimer's disease." Good news that merits further research.


Risk factors: Alzheimer's :
Enhanced by Zemanta

No comments: